Evidence mapPaperPMID 21723445Full record

ReviewAtherosclerosis2011

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Alberico L Catapano, Zeljko Reiner, Guy De Backer, Ian Graham, Marja-Riitta Taskinen, Olov Wiklund, Stefan Agewall, Eduardo Alegria, M John Chapman and 10 more

Erratum issued Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Atherosclerosis, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT03329729 (Non-interventional, Multicenter Clinical Trial to Investigate the Efficacy of Rosuvastatin in Patients With Hyperlipidemia and Other Cardiovascular Risk Factors.), which is not on this map. Cited by 59 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 2 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03329729 completedstarted 2018, after this paper: background citation

Non-interventional, Multicenter Clinical Trial to Investigate the Efficacy of Rosuvastatin in Patients With Hyperlipidemia and Other Cardiovascular Risk Factors.

Ran2018Enrolled4,700Registered outcomes3Posted comparisons0ConditionsDyslipidemias, Hyperlipidemias, Quality of Life, Risk Factor, CardiovascularArmsRosuvastatin
Open the trial in the graph
3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy.Clinical research in cardiology : official journal of the German Cardiac Society · 2019
    Pooled it
  2. Guideline
  3. Trial
  4. Trial
  5. Berberine and monacolin effects on the cardiovascular risk profile of women with oestroprogestin-induced hypercholesterolemia.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2014
    Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Metabolic Syndrome and Male Fertility.The world journal of men's health · 2019
    Review
  17. Observational
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

20 authors.

Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Alberico L Catapano
Zeljko Reiner
Guy De Backer
Ian Graham
Marja-Riitta Taskinen
Olov Wiklund
Stefan Agewall
Eduardo Alegria
M John Chapman
Paul Durrington
Serap Erdine
Julian Halcox
Richard Hobbs
John Kjekshus
Pasquale Perrone Filardi
Gabriele Riccardi
Robert F Storey
David Wood
ESC Committee for Practice Guidelines 2008-2010 and 2010-2012 Committees

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Practice Guidelines as TopicAdolescentAdultAgedAtherosclerosisCardiologyCardiovascular DiseasesChildCholesterolClinical Trials as TopicDyslipidemiasEuropeFemaleGenotypeHumansLife StyleCholesterolLipidsLipoproteins

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.